BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34422644)

  • 21. Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence.
    Stonesifer CJ; Djavid AR; Grimes JM; Khaleel AE; Soliman YS; Maisel-Campbell A; Garcia-Saleem TJ; Geskin LJ; Carvajal RD
    Front Oncol; 2021; 11():734354. PubMed ID: 34988009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Pre-malignant and Malignant Non-melanoma Skin Cancers: A Study from a Tertiary Care Hospital of North India.
    Bhat YJ; Zeerak S; Rasool F; Akhtar S; Shah IH; Yaseen A
    J Cutan Aesthet Surg; 2022; 15(2):118-123. PubMed ID: 35965913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of long interspersed element-1 protein immunoreactivity in cutaneous malignancies.
    Zolfaghari MA; Karimi A; Kalantari E; Korourian A; Ghanadan A; Kamyab K; Esmaili N; Emami Razavi AN; Madjd Z
    BMC Cancer; 2020 Jun; 20(1):567. PubMed ID: 32552892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonmelanoma skin cancer.
    Nguyen TH; Ho DQ
    Curr Treat Options Oncol; 2002 Jun; 3(3):193-203. PubMed ID: 12057065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment of basal cell carcinoma and squamous cell carcinoma.
    Gualdi G; Monari P; Apalla Z; Lallas A
    G Ital Dermatol Venereol; 2015 Aug; 150(4):435-47. PubMed ID: 26140396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up.
    Frankel DH; Hanusa BH; Zitelli JA
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):720-6. PubMed ID: 1583171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted therapy in nonmelanoma skin cancers.
    Spallone G; Botti E; Costanzo A
    Cancers (Basel); 2011 May; 3(2):2255-73. PubMed ID: 24212808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
    Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
    Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin Cancer: Squamous and Basal Cell Carcinomas.
    Bashline B
    FP Essent; 2019 Jun; 481():17-22. PubMed ID: 31188548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant cetuximab and radiation therapy: A possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas.
    Della Vittoria Scarpati G; Perri F; Pisconti S; Costa G; Ricciardiello F; Del Prete S; Napolitano A; Carraturo M; Mazzone S; Addeo R
    Mol Clin Oncol; 2016 Apr; 4(4):467-471. PubMed ID: 27073643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papillomaviruses in non-melanoma skin cancer: epidemiological aspects.
    Kiviat NB
    Semin Cancer Biol; 1999 Dec; 9(6):397-403. PubMed ID: 10712886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updates on the Management of Non-Melanoma Skin Cancer (NMSC).
    Fahradyan A; Howell AC; Wolfswinkel EM; Tsuha M; Sheth P; Wong AK
    Healthcare (Basel); 2017 Nov; 5(4):. PubMed ID: 29104226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy for nonmelanoma skin cancer: does it have a future?
    Urosevic M; Dummer R
    Cancer; 2002 Jan; 94(2):477-85. PubMed ID: 11900233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economic burden of occupational non-melanoma skin cancer due to solar radiation.
    Mofidi A; Tompa E; Spencer J; Kalcevich C; Peters CE; Kim J; Song C; Mortazavi SB; Demers PA
    J Occup Environ Hyg; 2018 Jun; 15(6):481-491. PubMed ID: 29695213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review of clinical outcomes for patients diagnosed with skin cancer spinal metastases.
    Goodwin CR; Sankey EW; Liu A; Elder BD; Kosztowski T; Lo SF; Fisher CG; Clarke MJ; Gokaslan ZL; Sciubba DM
    J Neurosurg Spine; 2016 May; 24(5):837-49. PubMed ID: 26544595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-melanoma skin cancer: new and future synthetic drug treatments.
    Amaral T; Garbe C
    Expert Opin Pharmacother; 2017 May; 18(7):689-699. PubMed ID: 28414587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HIV and cancer: Update 2020].
    Abbar B; Veyri M; Solas C; Poizot-Martin I; Spano JP
    Bull Cancer; 2020 Jan; 107(1):21-29. PubMed ID: 31980144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global incidence of incomplete surgical excision in adult patients with non-melanoma skin cancer: study protocol for a systematic review and meta-analysis of observational studies.
    Nolan GS; Wormald JCR; Kiely AL; Totty JP; Jain A
    Syst Rev; 2020 Apr; 9(1):83. PubMed ID: 32303259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between Autofluorescence Intensity and Histopathological Features in Non-Melanoma Skin Cancer: An Ex Vivo Study.
    Giovannacci I; Meleti M; Garbarino F; Cesinaro AM; Mataca E; Pedrazzi G; Reggiani C; Paganelli A; Truzzi A; Elia F; Giacomelli L; Magnoni C
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.